ThomasHowardCartwrightMD

Oncology • Ocala, FL

Hematologic Oncology

Co-Chairman US Oncology Gastrointestinal Research

Join to view full profile

Dr. Cartwright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cartwright's full profile

Already have an account?

Office
2329 SE 13th St
Ocala, FL 34471
Phone+1 352-804-1294
Is this information wrong?

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
Southern Illinois UniversityResidency, Internal Medicine, 1976 - 1979
Northwestern University The Feinberg School of MedicineClass of 1976

Certifications & Licensure

TN State Medical License 1980 - 2026
FL State Medical License 1981 - 2026
MD State Medical License 2022 - 2024
GA State Medical License 1979 - 2024
IL State Medical License 1977 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma Start of enrollment: 2010 Jun 01
Completed
Phase 2
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
Completed
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Start of enrollment: 2012 Apr 01
Active, not recruiting
Phase 3
MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10
Completed
Phase 2
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) Start of enrollment: 2015 Dec 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

11 citations
Quality of Care in Non–Small-Cell Lung Cancer: Findings From 11 Oncology Practices in Florida
Tawee Tanvetyanon, Michelle M. Corman, Ji-Hyun Lee, William J. Fulp, Fred Schreiber, Richard Brown, Richard M. Levine, Thomas H. Cartwright, Guillermo Abesada-Terk, Ge...> ;Journal of Oncology Practice. 2011 Nov 1
20 citations
Degree of Variability in Performance on Breast Cancer Quality Indicators: Findings From the Florida Initiative for Quality Cancer Care
Jhanelle E. Gray, Christine Laronga, Erin M. Siegel, Ji-Hyun Lee, William J. Fulp, Michelle Fletcher, Fred Schreiber, Richard Brown, Richard M. Levine, Thomas H. Cartw...> ;Journal of Oncology Practice. 2011 Jul 1
33 citations
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
J Russell Hoverman, Thomas H Cartwright, Debra A Patt, Janet L Espirito, Matthew P Clayton, Jody S Garey, Terrance J Kopp, Michael Kolodziej, Marcus A Neubauer, Kathry...> ;Journal of Oncology Practice. 2011 May 1
11 citations
Patients With Locally Advanced and Metastatic Colorectal Cancer Treated With Capecitabine Versus 5-Fluorouracil as Monotherapy or Combination Therapy With Oxaliplatin:...
Edward Chu, Kathy L. Schulman, Edward F. McKenna, Thomas H. Cartwright> ;Clinical Colorectal Cancer. 2010 Oct 1
10 citations
Initial evaluation of quality indicators for psychosocial care of adults with cancer.
Paul B. Jacobsen, David Shibata, Erin M. Siegel, Ji-Hyun Lee, Carlos Alemany, Richard Brown, Thomas H. Cartwright, Richard M. Levine, Jesusa Corazon R. Smith, Guillerm...> ;Cancer Control. 2009 Oct 1
7 citations
Pharmacoeconomic benefits of capecitabine-based chemotherapy in metastatic colorectal cancer.
Edward Chu, Thomas H. Cartwright> ;Journal of Clinical Oncology. 2008 May 1
200 citations
Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients
Hans-Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero, M. Nowacki, Arie Figer, Jean A. Maroun, Timothy J. Price, Robert Lim, Eric Van Cutsem, Young Suk Park, Jos...> ;Journal of Clinical Oncology. 2006 Jan 20
158 citations
Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic Cancer
Thomas H. Cartwright, Allen Lee Cohn, Jerry A. Varkey, Yin-Miao Chen, Ted P. Szatrowski, John Cox, J. Schulz> ;Journal of Clinical Oncology. 2002 Jan 1
99 citations
Hyperalimentation of the cancer patient with protein-calorie undernutrition.
Daniel W. Nixon, David H. Lawson, Michael Kutner, Joseph D. Ansley, Maurice Schwarz, Steve Heymsfield, Rajender K. Chawla, Thomas H. Cartwright, Daniel Rudman> ;Cancer Research. 1981 Jun 1
14 citations
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in ...
Ian Chau, Pilar García-Alfonso, Zdenĕk Linke, Ana Ruíz Casado, Eduardo Polo Marques, Pascaline Picard, Marina Celanovic, Thomas H. Cartwright> ;Cancers. 2020 Mar 11
30 citations
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
Thomas H. Cartwright, Monika Parisi, Janet L. Espirito, Thomas Wilson, Corey Pelletier, Manish Patel, Hani M. Babiker> ;Drugs - Real World Outcomes. 2018 Sep 1
29 citations
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
Bradley J. Monk, Philip E. Lammers, Thomas Cartwright, Ira Jacobs> ;Pharmaceuticals. 2017 Jan 28
75 citations
Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
Wen Wee Ma, Muhammad Wasif Saif, Bassel F. El-Rayes, Thomas H. Cartwright, James Posey, Thomas R. King, Reid von Borstel, Michael K. Bamat, Marwan Fakih> ;Cancer. 2017 Jan 15
4 citations
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non–Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care
Tawee Tanvetyanon, Ji-Hyun Lee, William J. Fulp, Fred Schreiber, Richard Brown, Richard M. Levine, Thomas H. Cartwright, Guillermo Abesada-Terk, George P. Kim, Carlos ...> ;Journal of Oncology Practice. 2015 Jul 1
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy ...
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki ...> ;The Lancet. Oncology. 2015-04-12
78 citations
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, con...
Daniel G. Haller, Michael O’Connell, Thomas H. Cartwright, Chris Twelves, Edward McKenna, Muhammad Wasif Saif, Steve Lee, Greg Yothers, H.-J. Schmoll> ;Annals of Oncology. 2015 Apr 1
7 citations
Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval
Paul B. Jacobsen, Ji-Hyun Lee, William J. Fulp, Erin M. Siegel, David Shibata, Christine Laronga, Jhanelle E. Gray, Tawee Tanvetyanon, Fred Schreiber, Richard Brown, R...> ;Journal of Oncology Practice. 2015 Jan 1
113 citations
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-rela...
Hans-Joachim Schmoll, Chris Twelves, Weijing Sun, Michael J. O'Connell, Thomas H. Cartwright, Edward McKenna, Muhammad Wasif Saif, Steve Lee, Greg Yothers, Daniel G. H...> ;The Lancet. Oncology. 2014 Dec 1
11 citations
Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval
Christine Laronga, Jhanelle E. Gray, Erin M. Siegel, Ji-Hyun Lee, William J. Fulp, Michelle Fletcher, Fred Schreiber, Richard Brown, Richard M. Levine, Thomas H. Cartw...> ;Journal of the American College of Surgeons. 2014 Oct 1
10 citations
Changes in the Care of Non–Small-Cell Lung Cancer After Audit and Feedback: The Florida Initiative for Quality Cancer Care
Tawee Tanvetyanon, Ji-Hyun Lee, William J. Fulp, Fred Schreiber, Richard Brown, Richard M. Levine, Thomas H. Cartwright, Guillermo Abesada-Terk, George P. Kim, Carlos ...> ;Journal of Oncology Practice. 2014 Apr 15
5 citations
Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial.
Edward Chu, Daniel G. Haller, Cartwright T, Chris Twelves, Jim Cassidy, Weijing Sun, Muhammad Wasif Saif, Edward McKenna, Steve Lee, H.-J. Schmoll> ;British Journal of Cancer. 2014 Mar 18
15 citations
Florida Initiative for Quality Cancer Care: Improvements on Colorectal Cancer Quality of Care Indicators during a 3-Year Interval
Erin M. Siegel, Paul B. Jacobsen, Ji-Hyun Lee, Mokenge P. Malafa, William J. Fulp, Michelle Fletcher, Jesusa Corazon R. Smith, Richard Brown, Richard M. Levine, Thomas...> ;Journal of the American College of Surgeons. 2014 Jan 1
Effect of the 12-gene colon cancer assay results on adjuvant treatment recommendations in patients with stage II colon cancer.
Cartwright, T.,Chao, C.,Lee, M.,Lopatin, M.,Bentley, T.,Broder, M.,Chang, E.> ;Curr Med Res Opin. 2013 Oct 17
34 citations
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Jeffrey R. Infante, Tony R. Reid, Allen Lee Cohn, William Jeffery Edenfield, Terrence P. Cescon, John T. Hamm, Imtiaz Malik, Thomas A. Rado, Philip J. McGee, Donald A....> ;Cancer. 2013 Jul 15
8 citations
Adverse Events Associated With Antiangiogenic Agents in Combination With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer and Their Management
Thomas H. Cartwright> ;Clinical Colorectal Cancer. 2013 Jun 1
Join now to see all

Lectures

Post hoc safety and effectiveness analysis of aflibercept + FOLFIRI for patients with metastatic colorectal cancer (mCRC) previously treated with antiepidermal growth ...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020